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Abstract

PATIENT SATISFACTION WITH SEDATION FOR PERIODONTAL SURGERY:
A RANDOMIZED, CROSS-OVER CLINICAL STUDY
By Jason Michael Streem, D.D.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of
Science in Dentistry at Virginia Commonwealth University.

Virginia Commonwealth University, 2011

Major Director: Thomas C. Waldrop, D.D.S., M.S.
Residency Program Director, Department of Periodontics

PURPOSE:

To create a study designed to assess patient satisfaction and

preference for oral versus intravenous sedation in conjunction with periodontal surgical
procedures.
METHODS: Twenty-six patients who required at least two periodontal surgery
procedures and requested sedation for treatment, participated in our study at VCU
Department of Periodontics. This was a randomized, cross-over design with groups
which received an intravenous sedative regimen with or without oral sedation
premedication for one surgery and oral sedation medication alone for the other surgery.
The primary outcome measurement was the type of sedation preferred by the subject.

vi

RESULTS: 14/26 (53.8%) subjects indicated a preference for intravenous
sedation, compared with 7/26 (26.9%) subjects who preferred oral sedation alone. 1/26
(3.8%) subject reported that they would prefer no sedation after experiencing both oral
and oral/intravenous combination sedation methods. 4/26 (15.3%) of the subjects who
completed the study reported “No Difference” with regards to their preference for either
method of sedation.
CONCLUSION: More subjects preferred intravenous sedation and would consent
to the sedation again for any future needed surgery. This study supports the need to offer
intravenous sedation with periodontal surgery

vii

INTRODUCTION
A large percentage of the population experience some degree of dental anxiety
and a sizable minority of the population are so anxious that they avoid dental treatment
altogether. 1 Some dentally anxious patients avoid dental treatment because of the fear of
pain while others reported slightly more fear about reprimands for poor oral hygiene and
shame for their dental anxiety. High dentally anxious subjects reported that they were
reluctant to talk about their anxiety with the dentist. 2 Among the prominent historical
causes of dental anxiety is the patient’s perception of mismanagement by the dentist,
greater sensitivity to pain, fear of an oral injection and the high-speed handpiece. 3
Despite these reasons, patient anxiety can be managed by using the appropriate stress
reduction technique to improve patient cooperation and operator performance. Included
in these techniques are oral and intravenous (IV) sedation.
Clinicians generally give oral premedication for oral sedation as a first
consideration in the management of the mildly apprehensive dental patient. Since it is
easier to administer, convenient and readily available at a reasonable cost, oral sedation is
one of the most popular peri-operative sedation modalities.
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Advantages of oral medication
1) convenience and simplicity as most people are familiar with taking medications in pill
form,
2) drugs are readily available by prescription,
3) there are no overhead costs to the dentist
4) drug reactions are generally less severe,
5) an oral route eliminates the need for premedication by intramuscular injection,
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6) oral sedation requires only minimal training, and
7) the duration of action can extend into the post-treatment period.
Disadvantages of oral medication;
1) minimal and unpredictable effects in extremely apprehensive patients,
2) possibility of noncompliance,
3) response to oral medications is unpredictable regardless of level of pre-operative
anxiety,
4) dosages are largely empirical, and
5) prescription costs can be high for only one or two doses. 5
Results with oral sedation agents are not always predictable and can exhibit
extremely variable responses.

The onset of action is dependent upon the rate of

absorption from the small intestine. A delay in the onset of action can also occur with a
decrease in gastric motility which may be related to increased anxiety. Once oral agents
have been absorbed, many will undergo a “first pass” metabolism through the liver which
ultimately determines the concentration of a drug that is available for binding at receptor
sites. 6 The dosages used for oral sedation are empirical and are usually based on body
weight. While most patients will respond in the desired manner, some may receive little
or no effect while others may become obtunded. 7 In some cases, oral sedation can be
effective when combined with intravenous agents for the management of moderate to
severe dental anxiety.
An alternative to oral sedation is IV sedation. Intravenous sedation was first
recorded in a scientific journal in 1665 when Sir Christopher Wren published his
experiments with injection of opium into a ligated vein of a dog using a quill and a
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bladder as syringe. 8 He reported, “By making ligatures on the veins, and then opening
them on the side of the ligature towards the heart, and by putting into them slender
syringes or quills, fastened to bladders containing the matter to be injected; performing
that operation upon pretty big and lean dogs, that the vessels might be large enough and
easily accessible.” He then injected opium into the easily accessible large vessels of the
hind legs of the dogs and reported, “the success was that opium, being soon circulated
into the brain did within a short time stupify, though not kill the dog.” In the 1960s and
1970s, the Jorgensen technique used this technique with a medium acting barbiturate,
pentobarbital, a narcotic, meperidine and scopolamine was a well established procedure
for many dentists for the control of apprehension, fear, and the relief of stress. 9,10
The advantages of intravenous administration of sedative drugs are well known;
notably, the ability to titrate dosage incrementally to a clinical end point with reliable and
less variable effect that can be obtained by the oral route. When administering drugs, the
intravenous route has the major advantage of being more predictable. The peak drug
plasma concentration is obtained nearly instantaneously because absorption delays are
bypassed. Onset of action of drugs administered by the intravenous route is the most
rapid of all the sedation techniques. Rapid onset of action is the principal advantage of
this route as well as the greatest safety feature. It allows for the titration of drugs in
small, incremental dosages until the clinical effects have been achieved. Maintenance of
intravenous access affords for the opportunity to sustain suitable levels of sedation for
longer procedures as additional sedative or analgesic drugs can be administered. In
addition, intravenous access allows for administration of resuscitative drugs. Compared
to a single oral dose, incremental dosing facilitates achievement of precise levels of
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sedation, with less danger of oversedation. 11 The degree of control over the level of
sedation afforded by the intravenous route allows for the optimal management of patients
exhibiting moderate to severe anxiety or fear of the dental setting.
Multiple drugs have been used for sedation including benzodiazepines and
narcotics.

Benzodiazepines have a specific anxiolytic, anticonvulsant, sedative, and

amnestic properties. Specific receptors for the benzodiazepines have been identified. The
locations of these receptors parallel the locations of both the major inhibitory
neurotransmitter in the brain, gamma-aminobutyric acid (GABA), and the major
inhibitory neurotransmitter in the spinal cord, glycine. Benzodiazepines enhance GABA
and glycine activity, thereby producing their therapeutic effects. Activation of the GABA
receptor causes membrane chloride channels to open, increasing the influx of negative
chloride ions through the cell membrane, thereby preventing depolarization of the
neuron. Benzodiazepines appear to selectively suppress areas of the CNS, exerting their
greatest inhibitory effects on the subcortical limbic system.

The hippocampus and

amygdala appear to play an important role in memory function. Disruption to these
structures prevents conversion of information into long-term memory, although memory
of prior events is not affected. Inhibition of these areas by benzodiazepines is responsible
for the anterograde amnesia characteristically produced by these drugs. 12

The

mechanism is selective and dose-related, acting on long-term memory and impairing the
acquisition of new information. The rate of distribution of these agents depends on the
lipid solubility. The elimination half-life for diazepam is from 20-100 hours. In addition,
diazepam has two active metabolites, desmethyldiazepam and oxazepam.
metabolites produce sedative effects.

Both

The sedative effects of the benzodiazepine
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medications have very been useful in contemporary dental surgery and are applicable in
both enteral and parenteral forms.
Lorazepam is a well established drug used for oral sedation that is a derivative of
diazepam

but

differs

from

the

other

benzodiazepines

structurally

and

pharmacokinetically. It has a central depressant effect in both oral and parenteral forms
that is 5x as potent as the same dose of diazepam. 13 This drug also produces long-lasting
anterograde amnesia. 14 Lorazepam has a delayed onset of action after oral administration
with a peak at 90 minutes and a duration of approximately six hours. It has a much
shorter half-life than diazepam and although some of the drug may be transformed to
other metabolites, it is primarily conjugated to glucuronic acid and excreted in this
inactive form.13 Some have found lorazepam 2.5-5mg to be effective for sedation but not
anxiolysis while prolonged drowsiness has been a significant side effect. 15,16
Occasionally, there are situations when a drug with a longer duration of action is
indicated and night sedation with lorazepam followed by a repeat dose on the morning of
the operation is beneficial for the pathologically anxious. 17
For intravenous conscious sedation, a baseline level of sedation using a
combination of short to medium duration drugs is used.

Diazepam has high lipid

solubility, rapidly crosses the blood-brain barrier, which results in a fast onset of action.
However, it is also rapidly distributed to peripheral fat, resulting in a fairly short duration
of action after a single dose, despite a prolonged elimination half-life and active
metabolites with even longer duration. Diazepam was first synthesized in 1961 and was
used principally as an orally administered tranquilizer and muscle relaxant. Chemically,
diazepam is a benzodiazepine. It has a powerful sedative, amnestic and muscle relaxant
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properties. Its main action is on the limbic system, the area of the brain concerned with
emotions and emotional response to external stimuli. Because of the reported amnesia
associated with the intravenous use of diazepam, a French dentist, Davidau 18 , first used it
for general dental procedures in 1965.

Alternatively, midazolam is a potent

imidobenzodiazepine with amnestic and anxiolytic properties. It is widely used for brief
diagnostic procedures, conscious sedation and for inducing general anesthesia.14
Moderate doses of short-acting narcotics such as fentanyl or meperidine are
frequently used in combination with benzodiazepines to potentiate the sedation while
providing mild analgesia, euphoria and psychologic detachment.11 Meperidine is one of
the most commonly used opioids for moderate sedation and analgesia. It acts on the mu
receptors found in the central nervous system as well as in the bowel. Its analgesic
properties include inducing sedation and reducing reaction to painful stimuli and motor
activity.

Meperidine is primarily metabolized in the liver.

Its side effects include

hypotension, histamine release, nausea and vomiting and respiratory depression. 19 The
combination of a sedative and analgesic (narcotic) has been shown to significantly reduce
the amount of sedative needed to achieve the clinical end-point. 20
With these characteristics in mind, these drugs can be used separately or in
combination methods to achieve anxiety control. Combination techniques utilizing oral
premedication followed by intravenous sedation were found to significantly reduce pretreatment anxiety. However, the use of an oral premedication did not reduce the amount
of intravenous drug required for sedation nor did it alter the time of discharge. 21
Selection of the appropriate technique, whether oral sedation or IV sedation, is
based on the degree of patient apprehension and should be individualized according to
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the sedative effect required, the need for amnesia, the need for an elevated pain threshold
and the duration of the dental procedure. The American Association of Periodontology
has taken a stance that advanced education in conscious sedation is extremely important
to periodontics, in which extensive and prolonged surgical procedures are
commonplace.29

Currently available sedative and analgesic drugs with conscious

sedation techniques, used in conjunction with invasive periodontal therapy, results in
patients having safe, non-traumatic treatment experiences. 22,23,24,25,26,27 This tends to
enhance public perception of periodontal treatment. 28,29,30
There have been several studies in the dental literature describing and comparing
various sedation protocols with a variety of sedation medications.

All of these

comparative studies looked at the efficacy of either an intravenous narcotic or barbiturate
in combination with intravenous diazepam or midazolam 31,32,33,34,35 , a direct comparison
of two intravenous benzodiazepines 36,37,38,39,40,41 or a direct comparison of an oral
benzodiazepine versus an intravenous or oral benzodiazepine monotherapy 42,43,44,45 . All
of these studies used the removal of 3rd molars as the test procedure. This procedure can
be done very quickly in contrast to many periodontal procedures, which take significantly
more time to complete. As such, a sedation protocol with more long acting agents must
be utilized. The intravenous sedation protocol at the Virginia Commonwealth University
Graduate Periodontics program includes the use of diazepam, midazolam and meperidine.
For oral sedation, the drug of choice is lorazepam.
Thus, the aim was to create a study designed to assess patient satisfaction and
preference for oral versus intravenous sedation in conjunction with periodontal surgical
procedures.
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METHODS & MATERIALS
Patient Population. A randomized, cross-over study was designed for healthy adult
outpatients who required multiple periodontal surgeries to include: osseous surgery,
extraction of teeth, guided bone regeneration, implant placement, and/or periodontal
plastic surgery. The Institutional Review Board of Virginia Commonwealth University
reviewed and approved this research protocol. Patients were recruited from the Virginia
Commonwealth University School of Dentistry from July 2009-October 2010.

44

subjects were screened and written informed consent was obtained based on the inclusion
criteria. Prior to consideration for sedation, each patient completed an extensive medical
history form, and when judged necessary, medical consults were obtained. Particular
attention was given to medications being taken by the patient. A baseline recording of
vital signs, including blood pressure and pulse, was performed. Patients were included in
the study if they: 1) 18 years of age and older; 2) required two or more periodontal
surgeries with sedation; and 3) were ASA (American Society of Anesthesiologists) Class
1 or 2. Patients were excluded from the study if they: 1) were younger than 18 years of
age; 2) were ASA Class 3 and 4; 3) were pregnant or lactating females; 4) had
uncontrolled systemic conditions; 5) had contraindications to sedation medications; 6)
had moderate to severe cognitive impairment; 7) take a benzodiazepine for a chronic
condition or 8) had been determined poor candidates for sedation by their primary care
physician. Consent was either in the form of a general consent for dental surgery or as a
specific informed consent for intravenous sedation.
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Procedure
General. All of the patients had paired or nearly identical operations that were
performed at separate sittings. The randomization of the sedation protocol was by coin
flip.

One operation was conducted with oral conscious sedation medication by

prescribing 1-2mg lorazepam 60 minutes prior to the appointment. The other surgery
was performed with or without oral premedication with 1-2mg lorazepam followed by
intravenous diazepam 5mg/ml, midazolam 1mg/ml and with or without meperidine
50mg/ml. The cross-over design of this study allowed for the subjects to be their own
control. The procedures were performed by graduate periodontal residents at the Virginia
Commonwealth University School of Dentistry Department of Periodontics.
Sedation. All patients were prescribed 1-2mg lorazepam to take 60 minutes prior
to the scheduled oral sedation surgical appointment. Many of the oral sedation subjects,
were prescribed to take an additional 1mg lorazepam prior to going to bed the night
before the surgical appointment.

In most cases but not all, patients scheduled for

intravenous sedation procedures premedicated with 1-2mg lorazepam 60 minutes prior to
their scheduled appointment.
All intravenous sedation procedures employed two titrated sedatives, either alone
or in conjunction with a proportional dose of a narcotic similar to those recommended by
Jorgensen. Sedatives used were diazepam and midazolam.
meperidine.

The narcotic used was

Following venipuncture with a 20-gauge catheter and release of the

tourniquet, a free inflow of 0.9% Sodium Chloride solution was established as
surrounding tissues were carefully observed. If no signs of hematoma or subcutaneous
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accumulation of fluids were noted, a test dose of no more than a few drops of diazepam
was administered through the intravenous line. After waiting one full minute for signs of
paradoxical reactions to the drugs, the diazepam was administered in small increments
over 2-3 minutes until a titrated baseline was obtained based on Verrill’s sign, ptosis,
slurred speech and drowsiness.

Diazepam was not used following initial baseline

sedation. A proportional amount of meperidine was then slowly administered followed
by 0.5mg of midazolam. Surgical sites were anesthetized with a combination of 2%
lidocaine containing 1:100,000 epinephrine and/or 4% articaine 1:100,000 epinephrine
and/or 0.5% bupivicaine 1:200,000 epinephrine by both nerve block and infiltration.
Conventional periodontal surgical operations employing full thickness mucoperiosteal
soft tissue flaps, osseous resection, tooth extractions with and without site preservation
(guided bone regeneration), sinus augmentations, dental implant placement and
periodontal plastic surgery were then accomplished. During the surgery, after oral local
anesthesia was given, midazolam was introduced into the intravenous line at a dosage of
0.5mg/ml and was given in small 1ml increments approximately every 10-20 minutes
throughout the surgery.
Post-sedation. At the conclusion of the surgery and sedation, an observational
period began in which vital signs were measured until the patient scored at least an 8
Aldrete score52 and vital signs were normal. At that time, the intravenous catheter was
removed and both written and verbal post-operative instructions were given to both the
patient and their escort. Patients were escorted to their car in a wheelchair by the resident
surgeon or sedating resident.
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Assessments
Anxiety. A pre-operative questionnaire assessing the patients’ demographics and
baseline anxiety was given at the pre-surgical appointment. The patients’ pre-operative
apprehension was assessed using both the Corah Dental Anxiety Scale1 (DAS) and a
Visual Analogue Scale (VAS). The DAS, through a short 4-item questionnaire consisting
of multiple-choice questions with only one possible answer, assesses State anxiety and
the degree of anticipatory anxiety generated by a dental treatment. State anxiety reflects
a transitory emotional state or condition that is characterized by subjective, consciously
perceived feelings of tension and apprehension, and heightened autonomic nervous
system activity. 46 In other words, State anxiety is the transitory affective response to an
anxiety-provoking situation which then ultimately retreats. A score of 9-12 indicates
moderate anxiety whereas a score of 13-14 indicates high anxiety and a score of 15-20
indicates severe dental anxiety and/or phobia. The 100-mm VAS 47 where 0 denoted no
anxiety about dental treatment and 100 denoted complete anxiety about dental treatment
was used to corroborate the DAS and give more data about the subjects’ baseline anxiety.
Amnesia. The patients completed a post-operative questionnaire immediately at
the conclusion of each procedure, while still under the influence of the sedation
medications, which included questions about their experience and his/her ability to recall
events during the period from the beginning to the conclusion of the appointment.
Cardiovascular and Respiratory function.

Heart rate, blood pressure, pulse

oximetry, and EKG were continuously monitored and recorded on a sedation record
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every 5 minutes throughout each procedure. The sedating dentist used a prechordial
stethoscope to monitor breath sounds throughout the procedure as well.
Surgeon’s ratings.

In each immediate post-operative period, each surgeon

recorded his/her impressions of the patients’ behavior during the surgery assessed by the
Modified Ramsay Sedation Score 48 , the North Carolina Behavioral Score 49 and the
Overall Effectiveness of Sedation Score 50 .
The Modified Ramsay Sedation Score assesses patients from one to six based on
their level of sedation. A score of one equals a patients who exhibits anxiety, agitation
and restlessness score of two corresponds to a patient who is cooperative, oriented and
tranquil; a score of three represents a patient who responds only to commands; a score of
four demonstrates a brisk response to stimulus, while a score of five demonstrates a
sluggish response to stimulus; and a score of six represents no response to forceful
stimulus. An ideal score under sedation is two.
The North Carolina Behavior Rating Scale allows the practitioner to assess
behavior at critical events of the procedure. Behavior ranging from quiet and cooperative
(1) to wild and defiant (4) is scored using this scale. The North Carolina Behavior Rating
Scale also allows for an overall effectiveness of sedation score, ranging from satisfactory
(1) to unsuccessful (4).
The surgeons rated the subjects’ depth of sedation with a classification of
Minimal, Moderate or Deep 51 . Minimal Sedation is defined as a medically controlled
state of depressed consciousness that allows protective reflexes to be maintained,
retention of the patient’s ability to maintain a patent airway independently, continuously
permits appropriate response by the patient to physical stimulus or verbal command all
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while ventilatory and cardiovascular functions are unaffected. Moderate Sedation is
defined as a drug induced depression of consciousness during which patients respond
purposefully to verbal commands, either alone or accompanied by light tactile stimulation
while no interventions are required to maintain a patent airway and stable cardiovascular
functions.

Deep Sedation is defined as a medically controlled state of depressed

consciousness or unconsciousness from which the patient is not easily aroused and may
be accompanied by a partial loss of protective reflexes and inability to respond to
physical stimulation or verbal commands.
An Aldrete score 52 was also recorded prior to release of the patient. The Aldrete
Score is a post-anesthesia (sedation) recovery scoring system which assesses activity,
respirations, circulation, consciousness, and oxygen saturation. Each category is scored
from 0 to 2. Each patient was not discharged from the clinic until they achieved an
Aldrete score of at least eight.
Patients’ ratings. The author (JMS) called the patient 24 hours post-operative
and asked the patient to complete a secondary post-operative questionnaire by phone
which included similar questions as immediately post-operative in order to determine
both amnesia and patient experience while not under the influence of the sedation
medications as well as others to gauge the patients’ preference of type of sedation and
willingness to be sedated one way or the other for a future periodontal procedure if
needed. Patients were asked if they experienced any nausea or vomiting during their
sedation experience and during the post-operative period. Patients were also asked about
their willingness to be sedated these ways for future periodontal procedures based on the
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regular cost of sedation in the graduate program clinic($175) as well as the usual and
customary cost of sedation in private practice ($350).

STATISTICAL ANALYSIS
The major goal of this report was to relate the preference of sedation method of
the patient at the end of the study to age, race gender, and baseline anxiety. To evaluate
this hypothesis analysis of variance was used. Secondary analyses included evaluating
relationships between method of sedation and surgeon’s evaluation of various aspects of
patient’s behavior during surgery. These relationships were evaluated with chi squared
analysis due to the categorical nature of the outcome. Additional secondary analyses
were done evaluating patients’ recall of critical events immediately after and 24 hours
after surgery.
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RESULTS
A total of 26 subjects (TABLE I) completed the study (17 Female / 9 Male) with a
mean age of 5412.9 years and a mean weight of 8216.9 kg. Patients were excluded or
dropped from the study population due to a change in their treatment plan, which did not
require two surgeries or a failure to accept the proposed treatment plan to address their
periodontal disease or partial edentulism.

The study population was predominantly

Caucasian (50.0%) and African-American (46.2%) with one subject that was Asian
(3.8%).

Treatments included quadrants of osseous resective surgery, multiple

extractions, guided bone regeneration, implant placement surgery and mucogingival
surgery (Figure 2).
Sedation Procedure. Of all 52 surgeries, 20/52 (38.5%) surgical patients were
premedicated the night prior to the periodontal surgery with lorazepam 1mg. Of the
intravenous sedations, only 2/26 (7.7%) subjects did not have oral premedication of
lorazepam 1-2mg.
Anxiety. Baseline anxiety measured by Corah’s Dental Anxiety Scale (DAS) and
Visual Analogue Scale (VAS) (TABLE II). Mean DAS score was 10.413.54 and
10.674.15 for females and males, respectively.

Mean VAS measurements were

51.2631.52 and 39.7834.19 for females and males, respectively. Baseline anxiety and
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DAS scores were not related in this sample of subjects’ to race, gender, age and whether
or not the individual had ever been sedated before. (ANOVA).
Amnesia. There was a significant difference in the amnesia between the two types
of sedation methods. Immediately following surgery, patients being sedated with oral
sedation medication alone reported 19.23% amnesia of local anesthetic administration,
50% amnesia of the initial incision/start of surgery, and 38.46% amnesia of suturing at
the end of the procedure. When asked 24 hours later, this same group reported 19.23%
amnesia of local anesthetic administration, 69.23% amnesia of the initial incision/start of
surgery, and 38.46% amnesia of suturing at the end of the procedure. In addition, after
24 hours, this group showed 57.69% amnesia of the post-operative instructions given to
them immediately following the surgery (TABLE III) (Figure 3).
In comparison, immediately following surgery, patients being sedated with a
combination of oral and intravenous sedation reported 23.08% amnesia of local
anesthetic administration, 69.23% amnesia of the initial incision/start of surgery, and
57.69% amnesia if suturing at the end of the procedure. When asked 24 hours later, this
group reported 46.15% amnesia of local anesthetic administration, 84.62% amnesia of the
initial incision/start of surgery, and 65.38% amnesia of suturing at the end of the
procedure. In addition, after 24 hours, this group showed 73.07% amnesia of the postoperative instructions given to them immediately following the surgery (TABLE IV)
(Figure 4).
When asked about the first thing they remembered after the surgery had been
completed, a large majority of subjects recalled getting into a wheelchair as their first
recalled event following surgery.

Placing the patient into a wheelchair is standard
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practice in this clinic following sedations, so it is not surprising that most subjects
remembered this, but there were unpredictable results with regard to duration of amnesia.
Some subjects didn’t remember the ride home after remembering the wheelchair after
surgery while other vividly remembered their ride home. These results seem to be
unrelated to the method of sedation. Many subjects recalled the placement intravenous
catheter or pre-sedation events such as getting into the dental chair or EKG monitor
placement when they were asked about events they recalled during the surgery.
Interestingly, many subjects recall remembering “everything” after being sedated with
oral sedation medication alone.
Surgeon’s Ratings. The surgeons’ ratings using the Modified Ramsay Sedation
Score (TABLE V) (Figure 5) indicated 3/26 (11.5%) of the subjects sedated with oral
sedation medication alone still exhibited anxiety and agitation and restlessness during the
procedure. These three patients exhibited a high to severe level of baseline anxiety.
12/26 (46.2%) of the subjects were cooperative, oriented and tranquil during the
procedure. 5/26 (19.2%) of these subjects responded only to commands. 2/26 (7.7%)
demonstrated a brisk response to a stimulus. 4/26 (15.4%) demonstrated a sluggish
response to a stimulus. During sedation of the subjects with a combination of both oral
and intravenous sedation medication, the surgeons’ ratings with the Modified Ramsay
Sedation Score indicated 0/26 (0%) of the subjects exhibited anxiety, agitation or
restlessness. 7/26 (26.9%) of subjects were cooperative, oriented and tranquil during the
procedure. 9/26 (34.6%) of these subjects responded only to commands. 1/26 (3.8%)
demonstrated a brisk response to a stimulus while 9/26 (34.6%) demonstrated a sluggish
response to a stimulus. No subject demonstrated a response only to forceful stimulus
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when sedated with either method. There was no statistical relationship between baseline
anxiety and how the subjects behaved during surgery. Also, the relationship between the
type of sedation and the subjects’ Modified Ramsay score was not significantly different
between the methods (chi squared test).
Using the North Carolina Behavioral Rating Scale (NCBRS) (TABLE VI) (Figure
6), the surgeons rated the subjects as “Quiet” utilizing oral sedation medication alone
20/26 (76.9%) of the procedures while 5/26 (19.2%) were rated as “Annoyed” and 1/26
(3.8%) was “Upset”. The five subjects who were rated as “Annoyed” (NCBRS-2) after
oral sedation all were scored as having moderate to severe baseline anxiety via both the
DAS and VAS. For subjects having oral/intravenous sedation, 24/26 (92.3%) were
“Quiet”, 1/26 (3.8%) was “Annoyed”, and 1/26 (3.8) was “Wild”. The “Wild” subject
had a baseline anxiety score in the high range on the DAS and in the severe range on the
VAS. The NCBRS was not different between the groups both by a continuous response
and by a categorized response t-test and/or McNemar’s test.
The surgeons’ ratings of Overall Effectiveness of Sedation (TABLE VII) (Figure
7) resulted in 17/26 (65.4%) of oral sedation only procedures were deemed successful in
that the patient slept throughout the procedure with minimal crying or movement at
critical events (i.e. local anesthesia administration, initial incision, osseous resection and
suturing). Only 9/26 (34.6%) of the oral sedations were deemed moderately successful in
that the patient showed moderate amounts of crying and movement at times other than
critical events, but behavior did not hinder the progress of sedation. When intravenous
sedation was combined with oral sedation, 24/26 (92.3%) of the sedation were successful,
1/26 (3.8%) was moderately successful and 1/26 (3.8%) was unsuccessful as the patient
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exhibited continuous crying and movement throughout the sedation and treatment was
hindered and performed with difficulty. There was a significant difference between PO
and IV sedation with regards to the relative success of the sedation, p = 0.0035, chi
squared test.
Depth of sedation as measured by the surgeons via the Modified Ramsay Sedation
Scale, the North Carolina Behavior Rating Scale and the Overall Effectiveness of
Sedation Scale show that more subjects had remaining anxiety and agitation with the oral
sedation medication alone compared to the intravenous sedation. In addition, fewer
subjects taking oral sedation alone exhibited signs of depth of sedation that required more
stimulatory action to rouse them whereas more intravenous sedation subjects required
verbal, light tactile and strong tactile stimulation to respond to commands. Still, most of
the subjects remained quiet or slightly annoyed during either method of sedation and
most of the surgeries were deemed successful or moderately successful by the operating
surgeons.
As seen by the surgeons, 17/26 (65.38%) of those sedated with oral medication
alone resulted in minimal sedation while 9/26 (34.62%) were judged to be moderately
sedated. After combination oral/intravenous sedation, as seen by the surgeons, 6/26
(23.08%) subjects were judged to minimally sedated, 19/26 (73.08%) were judged to be
moderately sedated and 1/26 (3.85%) resulted in deep sedation (TABLE VIII). There
was a significantly different depth of sedation between PO and IV( p = 0.0025).
No subject was discharged without an Aldrete score of at least 8. All patients
were stable at discharge with Aldrete scores of 10.
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Patient Ratings. All subjects except one reported feeling comfortable during the
surgery both immediately following each procedure as well as 24 hours later.

All

subjects except two reported feeling sleepy during the procedure immediately following
each procedure. When asked 24 hours later, 4/26 subjects reported not feeling sleepy
during the procedure utilizing oral sedation alone. When asked about how the subjects
spent the rest of their day following the procedure, 14 subjects and 16 subjects reported
sleeping for much of the day following oral sedation and oral/intravenous sedation,
respectively. Six oral sedation alone patients reported feeling groggy for the rest of the
day while eight of the oral/intravenous sedation subjects reported this same feeling. Six
oral sedation alone subjects reported being awake in the 24 hours following the surgery
while only two oral/intravenous sedation subjects reported being awake in the 24 hours
following the surgery.
After both procedures had been completed, 25/26 (96.2%) of subjects reported
that they would recommend this the oral/intravenous combination method of sedation to
someone else needing periodontal surgery, while 23/26 (88.5%) would recommend the
lorazepam by mouth alone method of sedation for periodontal surgery.

The same

percentages would agree to consent again in the future for these methods of sedation
based on their experiences (Figure 8). Interestingly, after the 1st surgery, every subject
recommended sedation to someone else needing periodontal surgery, would consent to be
sedated that way again in the future and cost of sedation did not affect consenting for
sedation in the future. The majority of subjects (24/26) agreed when asked if they would
consent to be sedated in the future based on the cost of the sedation method ($65 for oral
sedation monitoring and $175 for oral/intravenous combination sedation and monitoring)
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(Figure 9). Interestingly, a greater percentage of subjects (9/26) declined to consent for
future sedations in conjunction with periodontal surgery based on the increased usual and
customary fee of $350 for sedation monitoring (Figure 10). This indicates that a small
percentage of subjects will feel that cost for sedation is not worth the benefit whereas
most subjects prefer to be sedated for periodontal surgery regardless of cost.
Subjects showed greater satisfaction with the oral/intravenous sedation than oral
sedation alone (TABLE IX). Of the 26 subjects who completed the study, 14 (53.8%)
indicated a preference for “Intravenous” sedation, compared with 7/26 (26.9%) who
preferred “Oral” sedation alone. 1/26 (3.8%) reported that they would prefer no sedation
at all after experiencing both oral and oral/intravenous combination sedation methods.
4/26 (15.3%) of the subjects who completed the study reported “No Difference” with
regards to their preference for either method of sedation. Table IX illustrates that the
anxiety scores of those who had no preference for method of sedation were significantly
different from those who preferred oral sedation (p =0.05) (ANOVA and Tukey’s test for
multiple comparisons).

DISCUSSION
Preference.

The primary outcome measure of this study showed that more

subjects preferred intravenous sedation in conjunction with periodontal surgery to oral
sedation alone. Seeing a significant difference in depth of sedation between the two
methods combined with the primary outcome can be interpreted as more subjects
preferred the moderate sedation experience and would consent for it again. Interestingly
though, some subjects preferred to be minimally sedated or did not like the feeling of
being moderately sedated, which made a small number of subjects feel out of control, and
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therefore preferred the oral sedation alone. Still, some subjects found no difference in
their sedation experiences between the two methods and only one subject preferred to
have any future surgery completed with no sedation. The interpretation of these findings
highlight the fact that there remains significant variability in the responses to these two
methods of sedation.

Even though more periodontal surgery subjects in this study

preferred the more moderate sedation of the intravenous methods during their procedures
in this study, likely due to its titratability, approximately one-third of the subjects felt that
the intravenous sedation was worse than expected and had a better experience with oral
medication alone. If the population of this study represents the anxiety, behavior and
attitudes of most adult patients, then it is reasonable to conclude sedation should at least
be offered to periodontal surgery patients.
Anxiety. A subject may have scored in the high anxiety category in one scale and
the low or moderate anxiety in the other scale. These scores could be related between the
four subjects who had no preference for sedation method and the seven subjects who
preferred oral sedation. With this as the only significant connection between baseline
anxiety level and sedation method preference, it was difficult to predict which method
will be more satisfactory to an anxious patient desiring sedation in conjunction with
periodontal surgery. This interpretation is in agreement with Corah et al. who found that
there appears to be no relationship between the assessment of satisfaction and any of the
measures of anxiety.1 Previous reviews have discussed oral sedation use with patients
who have minimal dental anxiety whereas patients with more severe anxiety would
benefit from intravenous sedation.5,11 The present study cannot confirm this statement
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and further cannot confirm that baseline anxiety level is predictive of how a patient will
react to a certain sedation method.
Amnesia. When subjects were sedated with intravenous medications they showed
more amnesia of critical events during the surgery than those sedated with oral
medication alone. Although studies comparing the relative amnesia of oral lorazepam
and intravenous diazepam are few 53,54 , there are studies that measure relative amnesia
between other oral sedation medications and intravenous diazepam43,44,45,55,56 as well as
relative amnesia between intravenous diazepam and intravenous midazolam. Several of
these studies found that intravenous midazolam produced more profound and longer
lasting anterograde amnesia compared to intravenous diazepam.36,37,38,39,40,41 Relating the
results of all of these studies can show that intravenous and oral midazolam is a more
potent amnestic agent than oral lorazepam which is about as potent an amnestic agent
than intravenous diazepam but takes longer for onset. Results of O’Boyle et al.44
indicated that 15mg of midazolam PO is superior, in some respects, to a 10mg dose of IV
diazepam for conscious sedation in association with oral surgery.

So therefore,

importance of midazolam use in sedation has been elucidated by these studies to be the
major inducer of anterograde amnesia during oral and periodontal surgery. The amnestic
properties of diazepam are weaker relative to midazolam and the oral sedation
medications used in the present study. This is apparent when looking at the results of the
present study, which show significantly more amnesia of local anesthetic administration,
initial incisions, suturing and post-operative instructions following intravenous sedation
as compared to oral sedation alone and slightly more amnesia of the procedure 24 hours
after surgery as compared to immediately following surgery. Inevitably, it is what the

23

patient subsequently remembers of the procedure that is important, not what is recalled in
the post-operative period.
Satisfaction. Subjects in the present study would overwhelmingly consent again
for sedation for a future periodontal surgery procedure based on their experience with
sedation of both methods.

In addition, knowing that the cost of the sedation and

monitoring was waived for this study (the subjects were informed both at the peroperative appointment as well as at the 24 hour post-operative questionnaire that the cost
for the sedation and monitoring was $65 for oral sedation alone and $175 for intravenous
sedation), the subjects still would consent again for sedation in conjunction with a future
periodontal surgery based on the cost of sedation. Interestingly, many of the subjects,
when informed of the cost of intravenous sedation in a private practice setting
(approximately $300-$350), declined future consent for intravenous sedation in
conjunction with periodontal surgery after accepting to consent both based on their
experience and

the cost of sedation at the Virginia Commonwealth University

Department of Periodontics. This an interesting finding as 9/26 subjects thought that
being sedated for surgery was not worth the extra cost in a private practice setting while
only 2/26 subjects found that the cost of sedation in the school setting was not worth the
cost. This finding may be related to the current economic climate in the United States,
which may be resulting in many patients declining treatment options for periodontal
disease.

Interestingly, many other subjects would rather be sedated for periodontal

surgery regardless of the cost.
Limitations. A total of twenty-six subjects completed this study out of forty-four
that originally were accepted and consented to participate. All of the subjects who were
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dropped from the study failed to schedule their surgical appointments due to personal or
financial reasons and chose to delay or not accept treatment. The limited number of
subjects completing this study may result in limited statistical power. Also, the variation
in surgery type, experience of the surgeon and type and dosages of both sedation
medications and local anesthetic agents brings significant confounders to this study. In
this study the surgeons and patients were not blinded in any way as compared to previous
studies of this topic.

If this study were to be duplicated, addition of blinding

characteristics may be beneficial. Also, some of the questions in the questionnaires used
in this study have been previously tested and validated while many other questions in
these questionnaires have not. As it pertains to amnesia, it was not possible to correlate
the subjects’ perception of time for the duration of the procedure as compared to the
actual time elapsed for the completion of the procedure due to the type of question asked
in the subject questionnaire. A visual analogue scale from one to 3 hours would have
been a better choice than multiple choice questions to assess the subjects’ perception
elapsed time.

CONCLUSIONS
In conclusion, in this study more patients preferred to have periodontal surgery
while being intravenously sedated as compared to orally sedated.

The clinical

significance of this finding is that, at minimum, patients should be at least be offered
intravenous sedation with periodontal surgery because many of them will be more
satisfied with the surgical experience. These patients may have been subject to selection
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bias as they may have had higher baseline anxiety than patients who do not require
periodontal surgery. Though, this population likely represents typical periodontal surgery
patients in that they may be more anxious than other dental patients with regards to
periodontal treatment. In many cases, this may be apparent as this population required
periodontal surgery for disease developed over many years lacking in professional dental
care. These dental patients may very well illustrate the tremendous amount of anxiety
still pervasive in our society.
Additionally, baseline anxiety cannot be very accurately correlated to preferred
method of sedation. High baseline anxiety is no guarantee that intravenous sedation will
be successful and low to moderate baseline anxiety is no guarantee that oral sedation will
be successful. Sedation using either technique still remains highly variable between
patients. Amnesia was more profound after intravenous sedation compared to oral
sedation. Due to this finding, post-operative instructions must be given in writing as
most sedated subjects will not remember specific instructions 24hrs later. The surgeons
found that intravenous sedation typically resulted in moderate sedation and oral sedation
typically resulted in minimal sedation. The majority of subjects were quiet and wellbehaved for both surgeries with both methods resulting in successful sedations. The
patients mostly had good experiences and appreciated the low cost while many of the
patients would opt not to be sedated in private practice due to higher costs.
Future studies in this subject should measure anxiety both pre-op and post-op,
vital signs at each critical event, relative success of surgery (i.e. 100% root coverage
during mucogingival surgery or adequate pocket reduction during osseous resective
surgery, etc.), and amnesia by using photos or objects shown to patients during surgery.
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As technology advances, new sedation medications are developed and the mechanisms of
action of the benzodiazepines becomes more clear, future studies need to be completed to
understand the effect of these medications on the patient experience during periodontal
surgery, stability of cardiovascular and respiratory function and anterograde amnesia of
critical events during periodontal surgery.
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TABLE I. Subject

Demographics
N

Gender
Male
Female

9 34.6%
17 65.4%
26 Mean 54±12.9

Age (yrs)
Weight (kg)
Race

26 Mean 82±16.9
Asian
African American
Caucasian
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1 3.8%
12 46.2%
13 50.0%

TABLE II.

Baseline Anxiety
DAS

Anxiety (VAS)

Gender

N

Mean

Std Dev

N

Mean

Std Dev

Female

17.00

10.41

3.54

17.00

51.26

31.52

9.00

10.67

4.15

9.00

39.78

34.19

Male
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TABLE III.

Patients’ ability to recall events during surgery (PO only)

Surgical event

Day of
Surgery
Yes

% amnesia

24 hrs
Post-op
Yes

% amnesia

Administration of Local Anesthesia

21

19.23

21

19.23

Initial Incision

13

50.00

8

69.23

Suturing

16

38.46

16

38.46

Do you remember the post-op
instructions given to you after the
surgery?

N/A

N/A

11

57.69
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TABLE IV. Patients’

ability to recall events during surgery (PO/IV)

Surgical event

Administration of Local Anesthesia

Day
of
Surgery
Yes
%
amnesia
20
23.08

24
hrs
Post-op
Yes
%
amnesia
14
46.15

Initial Incision

8

69.23

4

84.62

Suturing

11

57.69

9

65.38

N/A

7

73.07

Do you remember the post-op instructions N/A
given to you after the surgery?
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TABLE V. Modified

Ramsay Sedation Score

PO

%

IV

%

1

3

11.5

0

0.0

2

12

46.2

7

26.9

3

5

19.2

9

34.6

4

2

7.7

1

3.8

5

4

15.4

9

34.6

6

0

0.0

0

0.0

123456-

patient who exhibits anxiety, agitation and restlessness
patient who is cooperative, oriented and tranquil
patient who responds only to commands
patient who demonstrates a brisk response to a stimulus
patient who demonstrates a sluggish response to stimulus
patient who does not demonstrate a response to a forceful stimulus
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TABLE VI.

1
2
3
4

North Carolina Behavioral Rating Score

PO

%

IV

%

20
5
1
0

76.9
19.2
3.8
0.0

24
1
0
1

92.3
3.8
0.0
3.8

1 - Quiet: patient quiet or sleeping with only extraneous, inconsequential movements
2 - Annoyed: patient cooperative for treatment but with 1 or 2 of the undesirable
behaviors
3 - Upset: patient noticeably disturbed, with 2-3 undesirable behaviors present, making
treatment difficult but possible
4 - Wild: patient extremely defiant with presence of all undesirable behaviors, making
treatment extremely difficult
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TABLE VII. Overall

Effectiveness of Sedation Scale

PO

%

IV

%

1
2

17
9

65.4
34.6

24
1

92.3
3.8

3
4

0
0

0.0
0.0

0
1

0.0
3.8

1 Successful: patient slept throughout procedure with minimal crying or movement at
critical events*
2 Moderately successful: successful sedation with moderate amounts of crying and
movement at times other than critical events,* but behavior did not hinder progress of
sedation
3 Mildly successful: treatment was accomplished as planned, but because of screaming
or combative movements throughout the sedation the progression of portions of the
treatment was hindered
4 Unsuccessful: continuous crying or movement throughout sedation; treatment was
performed with difficulty; the progression of all treatment was hindered

* Critical events include topical placement, penetration of the needle, initial incision,
initial activation of bur during osseous resection and suturing.
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TABLE VIII. Subject

Minimal
Moderate
Deep

depth of sedation
PO

%

IV

%

17
9
0

65.38
34.62
0.00

6
19
1

23.08
73.08
3.85

Minimal Sedation
A medically controlled state of depressed consciousness that allows protective reflexes to
be maintained, retains the patient's ability to maintain a patent airway independently and
continuously permits appropriate response by the patient to physical stimulation or verbal
command, e.g. “open your eyes.” Although cognitive function and coordination may be
impaired, ventilatory and cardiovascular functions are unaffected.
Moderate Sedation
A drug-induced depression of consciousness during which patients respond purposefully
to verbal commands, either alone or accompanied by light tactile stimulation. No
interventions are required to maintain a patent airway, and spontaneous ventilation is
adequate. Cardiovascular function is usually maintained.
Deep sedation
A medically controlled state of depressed consciousness or unconsciousness from which
the patient is not easily aroused. It may be accompanied by a partial loss of protective
reflexes, and includes the inability to maintain a patent airway independently and respond
purposefully to physical stimulation or verbal command. Patients may require assistance
in maintaining a patent airway and spontaneous ventilation may be inadequate.
Cardiovascular function is usually maintained.
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TABLE IX.

Preference for Sedation Method

Preferred method

Age(yrs)
N
Mean Std Dev

DAS
Mean Std Dev

Intravenous
No Difference
No Sedation
Oral

14
4
1
7

11.50
12.25
4.00
8.43

52.79
53.25
69.00
54.86

13.87
17.00
.
9.77
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3.84
2.50
.
2.23

Anxiety (VAS)
Mean Std Dev
49.43
81.50
0.00
30.21

32.10
12.34
.
22.93

Figure 1.

Preferred Method of Sedation
14

# of Subjects

12

10

8

6

4

2

0

Intravenous

Oral

No Difference
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No Sedation

Figure 2.

Type of Periodontal Surgery
18

16

# of Surgeries

14

12

10

8

6

4

2

0

Osseous
Surgery

Implant
Placement

Guided Bone
Regeneration
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Mucogingival
Surgery

Multiple
Extractions

Figure 3.

Patient Amnesia in Conjunction with PO
Sedation
Administration of Loc al Anesthesia
100
90

Intial Inc ision
Suturing
Post-op Instrc tions

% of Subjects

80
70
60
50
40
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20
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Immediately
Following Surgery

24 hrs post-op
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Figure 4.

Patient Amnesia in Conjunction with PO/IV
Sedation
Administration of Loc al Anesthesia

% of Subjects
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Suturing
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Post-op Instruc tions
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Figure 5.

Modified Ramsay Sedation Scale
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PO Sedation
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Figure 6.

North Carolina Behavior Rating Scale
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Figure 7.

Overall Effectiveness of Sedation Scale
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Figure 8.

Patient Would Consent Again Based on
Experience
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Figure 9.

Patient Would Consent Again Based on Current
Cost
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45

Figure 10.

Patient Would Consent Again Based on UCR
Cost
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2
0

Yes

No
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APPENDIX
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Appointment before the 1st sedation
Patient ID: __________
Surgeon ID: __________
Instructions: Please circle and/or write in your answer on this form. For those
questions requiring additional information, please write in your answer on this form
in the space provided.
Please write in Today’s Date: __________________ (mm/dd/yyyy)
Please write in Age of Patient: _____years
Please write in Patient Date of Birth: ________________ (mm/dd/yyyy)
1. Gender: a) Male b) Female
2. Race:
a) Asian or Pacific Islander: Persons having origins in any of the peoples of the
Far East, Southeast Asia, the Indian subcontinent, or the Pacific Islands. This
area includes, for example, China, Japan, Korea, the Philippine Islands and
Samoa.
b) African American (not of Hispanic origin): Person having origins in any of the
black ethnic groups.
c) Hispanic: Persons having origins in any of the Mexican, Puerto Rican, Cuban,
Central or South American or other Spanish Cultures, regardless of ethnicity.
d) Native American or Alaskan Native: Persons having origins in any of the
original peoples of North America, and who maintain cultural identification
through tribal affiliation or community recognition.
e) Caucasian (not of Hispanic origin): Persons having origins in any of the
original peoples of Europe, North Africa or the Middle East.
3. Tobacco smoking: a)Yes b) No
If yes please write in, Number of ____ pks/day

Number of ______ years smoking

4. If you had to go to the dentist tomorrow, how would you feel about it?
a) I would look forward to it as a reasonably enjoyable experience.
b) I wouldn't care one way or the other.
c) I would be a little uneasy about it.
d) I would be afraid that it would be unpleasant and painful.
e) I would be very frightened of what the dentist might do.
5. When you are waiting in the dentist's office for your turn in the chair, how do you
feel?
a) Relaxed.
b) A little uneasy.
c) Tense.
d) Anxious.
e) So anxious that I sometimes break out in a sweat or almost feel physically sick.

48

6. When you are in the dentist's chair waiting while he/she gets his/her drill ready to
begin working on your teeth, how do you feel?
a) Relaxed.
b) A little uneasy.
c) Tense.
d) Anxious.
e) So anxious that I sometimes break out in a sweat or almost feel physically sick.
7. You are in the dentist's chair to have your teeth cleaned. While you are waiting and
the dentist is getting out the instruments which he/she will use to scrape your teeth
around the gums, how do you feel?
a) Relaxed.
b) A little uneasy.
c) Tense.
d) Anxious.
e) So anxious that I sometimes break out in a sweat or almost feel physically sick.
8. Have you been sedated for any type of medical or dental procedure in the past?
a) Yes b) No
If no, skip to question 12.
By which form were you sedated and did you have a good or bad experience?
If you have never been sedated by the method listed please answer “Never”.
9. By mouth (pill) a) Never b) Good Experience c) Neutral d) Bad Experience
Please Describe why you had a bad experience:
10. Laughing gas (Nitrous Oxide)a) Never b) Good Experience c) Neutral d) Bad
Experience
Please Describe why you had a bad experience:
11. Intravenous (IV) a) Never b) Good Experience c) Neutral d) Bad Experience
Please Describe why you had a bad experience:
12. Have you been prescribed a sedative or tranquilizer by your medical doctor for
regular use? a) Yes b) No
If yes, please write in which medication and what dosage?
13.
Please mark your current level of anxiety or nervousness with a vertical line on the dotted
line.
0……………………………………………..50…………………….……………….…100
(100mm)
THANK YOU FOR PARTICIPATING IN OUR RESEARCH STUDY
VCU DEPARTMENT OF PERIODONTICS

49

Immediately after the 1st and 2nd surgeries
Patient ID: ______
Surgeon ID:_______
Instructions: Please circle and/or write in your answer on this form. For those
questions requiring additional information, please write in your answer on this form
in the space provided.
Today’s Date:_______________ (mm/dd/yyyy)
1. Were you comfortable during the surgery?
a) Yes b) No
2. Did you feel sleepy during the surgery?
a) Yes b) No
3. How long do you think the surgery lasted?
a) 15 minutes
b) 30 minutes
c) 1 hour
d) 3 hours
e) Unsure
4.
a)
b)
c)
d)

What events during the surgery do you remember? (Fill in all that apply)
Local Anesthetic administration
Initial incision
Suturing
Other
If Other, please write in:

5. What was your comfort level at the Local Anesthetic administration? (select unsure if
you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
6. What was your comfort level at the initial incision? (select unsure if you don’t
remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
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7. What was your comfort level at suturing? (select unsure if you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
8. What was your comfort level at any other portion of the surgery that you remember?
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
9. Was the sedation experience what you expected?
a) Yes b) No
If No, please write why?
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Survey for Surgeon following 1st and 2nd surgery
Surgeon ID: _____________
Patient ID: ________________
Instructions: Please circle and/or write in your answers on this form in the
additional space provided.
1. What was the Modified Ramsey Sedation score for the patient?(choose one answer)
_______
1 - patient who exhibits anxiety, agitation and restlessness
2 - patient who is cooperative, oriented and tranquil
3 - patient who responds only to commands
4 - patient who demonstrates a brisk response to a stimulus
5 - patient who demonstrates a sluggish response to stimulus
6 - patient who does not demonstrate a response to a forceful stimulus
2. What was the North Carolina Behavioral score for the patient? (Please circle one)
1 - Quiet: patient quiet or sleeping with only extraneous, inconsequential
movements
2 - Annoyed: patient cooperative for treatment but with 1 or 2 of the undesirable
behaviors
3 - Upset: patient noticeably disturbed, with 2-3 undesirable behaviors present,
making treatment difficult but possible
4 - Wild: patient extremely defiant with presence of all undesirable behaviors,
making treatment extremely difficult
3. How did the patient’s behavior affect the progression of treatment? (Please circle one)
1 Successful: patient slept throughout procedure with minimal crying or
movement at critical events*
2 Moderately successful: successful sedation with moderate amounts of crying
and movement at times other than critical events,* but behavior did not hinder
progress of sedation
3 Mildly successful: treatment was accomplished as planned, but because of
screaming or combative movements throughout the sedation the progression of
portions of the treatment was hindered
4 Unsuccessful: continuous crying or movement throughout sedation; treatment
was performed with difficulty; the progression of all treatment was hindered
4. Do you feel that these indices (Questions 1-3) are adequate for the accurate
assessment of the success of your sedation? Yes or No
5. What level of sedation did the patient achieve? (Please circle) Minimal
Deep
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Moderate

6. What was the Aldrete recovery score for the patient as they left the appointment?
(Circle applicable scores at right)
ACTIVITY
Able to move 4 extremities voluntarily or on command = 2
Able to move 2 extremities voluntarily or on command = 1
Able to move 0 extremities voluntarily or on command = 0
RESPIRATION
Able to deep breathe and cough freely = 2
Dyspnea or limited breathing = 1
Apneic = 0
CIRCULATION
BP" 20% of Preanesthetic level = 2
BP" 20-50% of Preanesthetic level = 1
BP" 50% of Preanesthetic level = 0
LEVEL OF CONSCIOUSNESS
Fully Awake = 2
Arousable on calling = 1
Not responding = 0
SKIN COLOR
Pink = 2
Pale, dusky blotchy, jaundiced, other = 1
Cyanotic = 0
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24 hrs post-operative after 1st surgery
Patient ID: 001
Called by:
Time & Date:________ am/pm ___________ (mm/dd/yyyy)
Instructions: Please circle and/or write in your answer on this form. For those
questions requiring additional information, please write in your answer on this form
in the space provided.
1. Were you comfortable during the surgery?
a) Yes b) No
2. Did you feel sleepy during the surgery?
a) Yes b) No
3. How long do you think the surgery lasted?
a) 15 minutes
b) 30 minutes
c) 1 hour
d) 3 hours
e) Unsure
4.
a)
b)
c)
d)

What events during the surgery do you remember? (circle all that apply)
Local Anesthetic administration
Initial incision
Suturing
Other
If Other, please write in:

5. What was your comfort level at the Local Anesthetic administration? (select unsure if
you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
6. What was your comfort level at the initial incision? (select unsure if you don’t
remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
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7. What was your comfort level at suturing? (select unsure if you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
8. What was your comfort level at any other portion of the surgery that you remember?
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
9. Was the sedation experience what you expected?
a) Yes b) No
If No, please write why?
10. Do you remember the post-operative instructions given to you after the surgery?
a) Yes b) No c) Some
11. What is the first thing you remember after the procedure? Please write in:

12. Did you experience any nausea/vomiting after the surgery?
a) Yes b) No
13. Did you take your pain medication as directed?
a) Yes b) No
14. How did you spend the rest of your day after the surgery?
a) Awake
b) Groggy
c) Asleep
15. Would you recommend this type of sedation to someone else needing Periodontal
surgery? a) Yes
b) No
16. Would you consent to be sedated this way again for future Periodontal procedures
based on your experience? a) Yes
b) No
17. Would you consent to be sedated this way again for future Periodontal procedures
based on the cost of the sedation? a) Yes
b) No
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24 hrs post-operative after 2nd surgery
Patient ID: _____
Called by:
Time & Date: _________ am/pm ____________(mm/dd/yyyy)
Instructions: Please circle and/or write in your answer on this form. For those
questions requiring additional information, please write in your answer on this form
in the space provided.
1. Were you comfortable during the surgery?
a) Yes b) No
2. Did you feel sleepy during the surgery?
a) Yes b) No
3. How long do you think the surgery lasted?
a) 15 minutes
b) 30 minutes
c) 1 hour
d) 3 hours
e) Unsure
4.
a)
b)
c)
d)

What events during the surgery do you remember? (circle all that apply)
Local Anesthetic administration
Initial incision
Suturing
Other
If Other, please write in:

5. What was your comfort level at the Local Anesthetic administration? (select unsure if
you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
6. What was your comfort level at the initial incision? (select unsure if you don’t
remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
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7. What was your comfort level at suturing? (select unsure if you don’t remember)
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
8. What was your comfort level at any other portion of the surgery that you remember?
a) Very comfortable
b) Somewhat comfortable
c) Unsure
d) Somewhat uncomfortable
e) Very uncomfortable
9. Was the sedation experience what you expected?
a) Yes b) No
If No, please write why?
10. Do you remember the post-operative instructions given to you after the surgery?
a) Yes b) No c)Some
11. What is the first thing you remember after the procedure? Please write in answer.
12. Did you experience any nausea/vomiting after the surgery?
a) Yes b) No
13. Did you take your pain medication as directed?
a) Yes b) No
14. How did you spend the rest of your day after the surgery?
a) Awake
b) Groggy
c) Asleep
15. Would you recommend this type of sedation to someone else needing Periodontal
surgery? a) Yes
b) No
16. Would you consent to be sedated this way again for future Periodontal procedures
based on your experience? a) Yes
b) No
17. Would you consent to be sedated this way again for future Periodontal procedures
based on the current fee of 150 for IV? $35 for Oral? a) Yes
b) No
18. What is your preferred method of sedation?
a) Oral (pill form)
b)IV (intravenous) c) No Sedation

57

19. The usual and customary cost for conscious sedation in private practice is roughly
$350. Knowing this, would you be willing to pay this amount for the sedation experience
in conjunction with your periodontal surgery if needed in the future? a) Yes
b) No
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